Dutasteride: a guide to its use as monotherapy in benign prostatic hyperplasia

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.24, Iss.7, 2008-07, pp. : 5-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Silodosin: a guide to its use in benign prostatic hyperplasia

By Keating Gillian M. Curran Monique P.

Drugs & Therapy Perspectives, Vol. 28, Iss. 4, 2012-04 ,pp. : 1-4

Adis International

Access to resources Recommend Favorite

Dutasteride for the treatment of benign prostatic hyperplasia

By Wu Christopher Kapoor Anil

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 10, 2013-07 ,pp. : 1399-1408

Informa Healthcare

Access to resources Recommend Favorite

Dutasteride/Tamsulosin: In Benign Prostatic Hyperplasia

By Keating Gillian M.

Drugs & Aging, Vol. 29, Iss. 5, 2012-05 ,pp. : 405-419

Adis International

Access to resources Recommend Favorite

Dutasteride improves QOL in benign prostatic hyperplasia

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 428, 2003-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Dutasteride: a novel dual inhibitor of 5α-reductase for benign prostatic hyperplasia

By Djavan Bob Milani Shirin Fong Yan Kit

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 2, 2005-02 ,pp. : 311-317

Informa Healthcare

Access to resources Recommend Favorite